| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/JAMA.297.17.1892 |
| P698 | PubMed publication ID | 17473299 |
| P50 | author | Philippe Gabriel Steg | Q16027739 |
| Andrzej Budaj | Q60835867 | ||
| Christopher B. Granger | Q62050240 | ||
| Keith Fox | Q72227369 | ||
| Expanded Global Registry of Acute Coronary Events (GRACE2) Investigators | Q84260402 | ||
| Shaun G Goodman | Q91304252 | ||
| Joel M. Gore | Q114292273 | ||
| Kim A. Eagle | Q124746419 | ||
| P2093 | author name string | Marcus D Flather | |
| Frederick A Anderson | |||
| Ann Quill | |||
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heart failure | Q181754 |
| acute coronary syndrome | Q266018 | ||
| P304 | page(s) | 1892-1900 | |
| P577 | publication date | 2007-05-01 | |
| P1433 | published in | The Journal of the American Medical Association | Q1470970 |
| P1476 | title | Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006 | |
| P478 | volume | 297 |
| Q37310409 | "I'm not just a heart, I'm a whole person here": a qualitative study to improve sexual outcomes in women with myocardial infarction |
| Q22241919 | 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines |
| Q35696662 | 25 year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: a Danish nationwide cohort study |
| Q34648516 | 30-year trends in heart failure in patients hospitalized with acute myocardial infarction. |
| Q37271417 | A European perspective on improving acute systems of care in STEMI: we know what to do, but how can we do it? |
| Q33928930 | A call to action: responding to the future forecasting of cardiovascular disease in america |
| Q36329165 | A cross-sectional multicentre study of cardiac risk score use in the management of unstable angina and non-ST-elevation myocardial infarction |
| Q34707768 | A decade of changes in clinical characteristics and management of elderly patients with non-ST elevation myocardial infarction admitted in Italian cardiac care units |
| Q64067007 | A smartphone-assisted pressure-measuring-based diagnosis system for acute myocardial infarction diagnosis |
| Q47237585 | A systematic review and meta-analysis evaluating ischemic conditioning during percutaneous coronary intervention |
| Q38570927 | Acute Complications of Myocardial Infarction in the Current Era: Diagnosis and Management |
| Q36863886 | Acute coronary syndrome in the older adults |
| Q94456080 | Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high-risk combination. A statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology |
| Q35572081 | Acute coronary syndromes in the community |
| Q36166356 | Acute coronary syndromes: an old age problem |
| Q43219099 | Acute coronary syndromes: clinical characteristics, management, and outcomes at the American University of Beirut Medical Center, 2002-2005. |
| Q37998114 | Acute coronary syndromes: considerations for improved acceptance and implementation of management guidelines |
| Q54069247 | Acute myocardial infarction |
| Q43662996 | Acute myocardial infarction in New York State: 1996-2008. |
| Q35202546 | Adherence to guidelines for the prescription of secondary prevention medication at hospital discharge after acute coronary syndrome: a multicentre study |
| Q42634527 | Age-dependent improvements in survival after hospitalisation with acute myocardial infarction: an analysis of the Myocardial Ischemia National Audit Project (MINAP). |
| Q27025350 | Air travel considerations for the patients with heart failure |
| Q33925329 | An international randomised placebo-controlled trial of a four-component combination pill ("polypill") in people with raised cardiovascular risk |
| Q26824864 | Anticoagulants for secondary prevention after acute myocardial infarction: lessons from the past decade |
| Q92264314 | Applying WCACG modified process is beneficial on reduced door-to-balloon time of acute STEMI patients |
| Q39745969 | Association of statin therapy with ventricular arrhythmias among patients with acute coronary syndrome |
| Q90399012 | Atherothrombotic risk stratification after acute myocardial infarction: The Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention in the light of the French Registry of Acute ST Elevation or non-ST Elevation Myocardial Infarction |
| Q47355559 | BLT1 antagonist LSN2792613 reduces infarct size in a mouse model of myocardial ischaemia-reperfusion injury |
| Q37055808 | Baseline characteristics, management practices, and in-hospital outcomes of patients with acute coronary syndromes: Results of the Saudi project for assessment of coronary events (SPACE) registry. |
| Q53301334 | Benefit of β-blocker treatment for patients with acute myocardial infarction and preserved systolic function after percutaneous coronary intervention. |
| Q38012078 | Bleeding complications in patients with acute coronary syndromes: are they important and how can we prevent them? |
| Q56837753 | Bleeding complications in primary percutaneous coronary intervention of ST-elevation myocardial infarction in a radial center |
| Q44811477 | Cardiac diffusion-weighted MR imaging in recent, subacute, and chronic myocardial infarction: a pilot study. |
| Q53098674 | Cardioprotective effect of resveratrol analogue isorhapontigenin versus omega-3 fatty acids in isoproterenol-induced myocardial infarction in rats. |
| Q44358956 | Cardiovascular disease and chronic kidney disease: from treatment to promoting health |
| Q34071675 | Changes in clinical profile, treatment, and mortality in patients hospitalised for acute myocardial infarction between 1985 and 2008 |
| Q34142216 | Changes in treatment and mortality of acute myocardial infarction in Estonian tertiary and secondary care hospitals in 2001 and 2007. |
| Q35629804 | Changing Trends in, and Characteristics Associated with, Not Undergoing Cardiac Catheterization in Elderly Adults Hospitalized with ST-Segment Elevation Acute Myocardial Infarction |
| Q89674842 | Clinical Competence in ST-segment Elevation Myocardial Infarction Management by Recently Graduated Physicians Applying for a Medical Residency Program |
| Q37647406 | Clinical Outcomes in Diabetic Patients Who Underwent Percutaneous Coronary Intervention during the Plain Old Balloon Angioplasty (POBA)-, Bare Metal Stents (BMS)- and Drug-eluting Stents (DES)-eras from 1984 to 2010. |
| Q36821026 | Clinical and economic outcomes among hospitalized patients with acute coronary syndrome: an analysis of a national representative Medicare population |
| Q64121409 | Clinical impact of a structured secondary cardiovascular prevention program following acute coronary syndromes: A prospective multicenter healthcare intervention |
| Q33750028 | Clinical review: bleeding - a notable complication of treatment in patients with acute coronary syndromes: incidence, predictors, classification, impact on prognosis, and management |
| Q37786639 | Clopidogrel in acute coronary syndrome: implications of recent study findings |
| Q38248586 | Comparative care and outcomes for acute coronary syndromes in Central and Eastern European Transitional countries: A review of the literature |
| Q89696027 | Comparison of the TIMI, GRACE, PAMI and CADILLAC risk scores for prediction of long-term cardiovascular outcomes in Taiwanese diabetic patients with ST-segment elevation myocardial infarction: From the registry of the Taiwan Society of Cardiology |
| Q40456101 | Confocal microscopy and biochemical analysis reveal spatial and functional separation between anandamide uptake and hydrolysis in human keratinocytes. |
| Q38186094 | Contemporary anticoagulation therapy in patients undergoing percutaneous intervention |
| Q38197732 | Contemporary antiplatelet therapy in patients undergoing percutaneous coronary intervention |
| Q53733243 | Continuous ECG Monitoring in Patients With Acute Coronary Syndrome or Heart Failure: EASI Versus Gold Standard. |
| Q81161972 | Coronary artery disease in India: challenges and opportunities |
| Q36693142 | Decade-Long Trends (2001-2011) in the Incidence and Hospital Death Rates Associated with the In-Hospital Development of Cardiogenic Shock after Acute Myocardial Infarction |
| Q33648660 | Decade-long trends in the magnitude, treatment, and outcomes of patients aged 30 to 54 years hospitalized with ST-segment elevation and non-ST-segment elevation myocardial infarction |
| Q33498652 | Declining mortality following acute myocardial infarction in the Department of Veterans Affairs Health Care System |
| Q43435391 | Decreasing trends in the incidence of heart failure after acute myocardial infarction from 1993-2004: a study of 175,216 patients with a first acute myocardial infarction in Sweden |
| Q51476427 | Delays in presentation with acute coronary syndrome in people with coronary artery disease in Australia and New Zealand. |
| Q34491985 | Dermal filler injection: a novel approach for limiting infarct expansion |
| Q34479931 | Design and rationale of the Reduction of Infarct Expansion and Ventricular Remodeling with Erythropoietin after Large Myocardial Infarction (REVEAL) trial |
| Q64101522 | Development and Validation of a Novel Risk Score for In-Hospital Major Bleeding in Acute Myocardial Infarction:-The SWEDEHEART Score |
| Q36230443 | Dexrazoxane Shows No Protective Effect in the Acute Phase of Reperfusion during Myocardial Infarction in Pigs |
| Q90299335 | Differences of in-hospital outcomes within patients undergoing percutaneous coronary intervention at institutions with high versus low procedural volume: a report from the Japanese multicentre percutaneous coronary intervention registry |
| Q89129041 | Discharge timing and outcomes after uncomplicated non-ST-segment elevation acute myocardial infarction |
| Q36860731 | Disparities in a provision of in-hospital post-arrest interventions for out-of-hospital cardiac arrest (OHCA) in the elderly population-protocol for a systematic review |
| Q40092427 | Does Using Complementary Health Insurance Affect Hospital Length of Stay? Evidence from Acute Coronary Syndrome Patients. |
| Q22242892 | ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC) |
| Q51873417 | Early intervention: which patients and how early? |
| Q24236794 | Early invasive versus conservative strategies for unstable angina and non-ST elevation myocardial infarction in the stent era |
| Q34471018 | Early revascularization is beneficial across all ages and a wide spectrum of cardiogenic shock severity: A pooled analysis of trials. |
| Q33818788 | Economic burden of illness of acute coronary syndromes: medical and productivity costs |
| Q40116416 | Editor's Choice-Medically managed patients with non-ST-elevation acute myocardial infarction have heterogeneous outcomes, based on performance of angiography and extent of coronary artery disease. |
| Q84967217 | Effect of acute heart failure following discharge in patients with non-ST-elevation acute coronary syndrome on the subsequent risk of death or acute myocardial infarction |
| Q61821140 | Effect of oral β-blocker treatment on mortality in contemporary post-myocardial infarction patients: a systematic review and meta-analysis |
| Q41044641 | Effective universal health coverage and improved 1-year survival after acute myocardial infarction: the Chilean experience |
| Q90115319 | Elevated plasma S100A1 level is a risk factor for ST-segment elevation myocardial infarction and associated with post-infarction cardiac function |
| Q62743772 | Enabling Precision Cardiology Through Multiscale Biology and Systems Medicine |
| Q59453611 | Evaluating strategies for behavior change to reduce cardiovascular risk |
| Q64974293 | Evaluation and Management of ST-elevation Myocardial Infarction and Shock. |
| Q37867315 | Evaluation and management of shock States: hypovolemic, distributive, and cardiogenic shock |
| Q55030205 | Evaluation of the CRUSADE Risk Score for Predicting Major Bleeding in Patients with Concomitant Kidney Dysfunction and Acute Coronary Syndromes. |
| Q35778912 | Evaluation of the Methods and Management of Acute Coronary Events (EMMACE)-3: protocol for a longitudinal study |
| Q38392992 | Excess mortality and guideline-indicated care following non-ST-elevation myocardial infarction |
| Q51577387 | Factors related to heart rupture in acute coronary syndromes in the Global Registry of Acute Coronary Events. |
| Q64892945 | Feasibility of identifying important changes in care management resulting from cardiovascular magnetic resonance (CMR) using hospital episode data in patients who activate the primary percutaneous coronary intervention (PPCI) pathway. |
| Q39423441 | Fifteen-year trends in the management of cardiogenic shock and associated 1-year mortality in elderly patients with acute myocardial infarction: the FAST-MI programme |
| Q37538031 | Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association |
| Q45931831 | Frequency and safety of switching antithrombin therapy at a regional PCI center. |
| Q37034400 | Genetics of late-onset Alzheimer's disease: progress and prospect. |
| Q30761633 | German nationwide data on current trends and management of acute myocardial infarction: discrepancies between trials and real-life |
| Q46125254 | HORIZONS trial: a step forward for primary percutaneous coronary intervention |
| Q33728256 | Has the frequency of bleeding changed over time for patients presenting with an acute coronary syndrome? The global registry of acute coronary events |
| Q22306347 | Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee |
| Q22306345 | Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association |
| Q22306356 | Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association |
| Q22241921 | Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association |
| Q30238784 | Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association |
| Q29547236 | Heart disease and stroke statistics--2011 update: a report from the American Heart Association |
| Q29547909 | Heart disease and stroke statistics--2012 update: a report from the American Heart Association |
| Q29547691 | Heart disease and stroke statistics--2014 update: a report from the American Heart Association |
| Q67223888 | Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial |
| Q35951074 | Home medicines reviews following acute coronary syndrome: study protocol for a randomized controlled trial |
| Q37023827 | Human embryonic stem cells and cardiac repair |
| Q36601679 | Identification of myocardial injury in the emergency setting |
| Q56986575 | Identifying needs and opportunities for advancing translational research in cardiovascular disease |
| Q30470429 | Imaging techniques in acute coronary syndromes: a review |
| Q37081717 | Impact of National Clinical Guideline recommendations for revascularization of persistently occluded infarct-related arteries on clinical practice in the United States |
| Q39441663 | Impact of initial hospital diagnosis on mortality for acute myocardial infarction: A national cohort study |
| Q90427628 | Impact of the Charlson Comorbidity Index score on risk prediction by single-photon emission computed tomography myocardial perfusion imaging following myocardial infarction |
| Q58158747 | Improved outcome of cardiogenic shock at the acute stage of myocardial infarction: a report from the USIK 1995, USIC 2000, and FAST-MI French Nationwide Registries |
| Q50094174 | Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014. |
| Q35822223 | Improved treatment and prognosis after acute myocardial infarction in Estonia: cross-sectional study from a high risk country |
| Q41232859 | In-hospital management and outcomes of acute coronary syndromes in relation to prior history of heart failure. |
| Q57474828 | In-hospital mortality of patients with cardiogenic shock after acute myocardial infarction; impact of early revascularization |
| Q50577959 | Incidence and outcome of first myocardial infarction according to gender and age in Denmark over a 35-year period (1978-2012). |
| Q37184347 | Incidence, prognosis, and factors associated with cardiac arrest in patients hospitalized with acute coronary syndromes (the Global Registry of Acute Coronary Events Registry). |
| Q36932653 | Indicators of quality of care for patients with acute myocardial infarction |
| Q51124971 | Initial complications and factors related to prehospital mortality in acute myocardial infarction with ST segment elevation. |
| Q33559154 | Intra-aortic balloon pump in patients with cardiogenic shock complicating myocardial infarction: a systematic review and meta-analysis of randomized trials (protocol). |
| Q37703477 | Intramyocardial Injection of Recombinant Adeno-Associated Viral Vector Coexpressing PR39/Adrenomedullin Enhances Angiogenesis and Reduces Apoptosis in a Rat Myocardial Infarction Model |
| Q46105785 | Ischaemia versus bleeding: the art of clinical decision-making |
| Q94703862 | Lessons learned from the CRUSADE National Quality Improvement Initiative |
| Q58788939 | Liver-heart crosstalk controls IL-22 activity in cardiac protection after myocardial infarction |
| Q39829099 | LombardIMA: a regional registry for coronary angioplasty in ST-elevation myocardial infarction |
| Q38407290 | Long-term excess mortality associated with diabetes following acute myocardial infarction: a population-based cohort study |
| Q58699927 | Long-term use of carvedilol in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention |
| Q48661771 | Low-density lipoprotein cholesterol targeting with pitavastatin + ezetimibe for patients with acute coronary syndrome and dyslipidaemia: the HIJ-PROPER study, a prospective, open-label, randomized trial |
| Q56988410 | Lower long-term mortality within a regional system of care for ST-elevation myocardial infarction |
| Q40084154 | Lumped parameter thermal model for the study of vascular reactivity in the fingertip |
| Q37812993 | MRI in acute myocardial infarction |
| Q50961980 | Major bleeding risk prediction using Chronic Kidney Disease Epidemiology Collaboration and Modification of Diet in Renal Disease equations in acute coronary syndrome. |
| Q37291860 | Management and outcomes of patients presenting with STEMI by use of chronic oral anticoagulation: results from the GRACE registry |
| Q90652486 | Management of Refractory Ventricular Fibrillation: Extracorporeal Membrane Oxygenation or Epinephrine? |
| Q37984773 | Management of acute coronary syndrome: achievements and goals still to pursue. Novel developments in diagnosis and treatment |
| Q37492551 | Management of acute coronary syndromes in Mexico: gaps and opportunities to improve outcomes |
| Q37141014 | Management of patients with acute coronary syndromes in real-world practice in Italy: an outcome research study focused on the use of ANTithRombotic Agents: the MANTRA registry |
| Q37939245 | Mapping geographic areas of high and low drug adherence in patients prescribed continuing treatment for acute coronary syndrome after discharge |
| Q35021114 | Medication Management Among Medicaid Myocardial Infarction Survivors |
| Q37859527 | Medium-term effects of cardiac rehabilitation in Germany: systematic review and meta-analysis of results from national and international trials |
| Q40113454 | Microcirculatory function and left ventricular recovery after STEMI, exploring the hidden territories |
| Q37052474 | Molecular basis of cardioprotective effect of antioxidant vitamins in myocardial infarction |
| Q33906082 | Monitoring guideline adherence in the management of acute coronary syndrome in hospitals: design of a multicentre study |
| Q45899581 | Mortality and missed opportunities along the pathway of care for ST-elevation myocardial infarction: a national cohort study. |
| Q53141587 | Mortality trends for non-ST-segment elevation myocardial infarction (NSTEMI) in the United States from 1988 to 2004. |
| Q52803111 | Multimorbidity and survival for patients with acute myocardial infarction in England and Wales: Latent class analysis of a nationwide population-based cohort. |
| Q34522451 | National patterns of risk-standardized mortality and readmission for acute myocardial infarction and heart failure. Update on publicly reported outcomes measures based on the 2010 release |
| Q37227932 | National trends in rates of death and hospital admissions related to acute myocardial infarction, heart failure and stroke, 1994-2004. |
| Q46265822 | Nationwide trends in the age adjusted prevalence of non-ST elevation myocardial infarction (NSTEMI) across various races and gender in the USA. |
| Q41961248 | New oral anticoagulants - will they be used with antiplatelet drugs in patients with atrial fibrillation after acute coronary syndrome? |
| Q88196011 | No Racial Disparities in the Treatment of ST Elevation Myocardial Infarction - A Community-based Experience |
| Q58812220 | Nurse-led Early Triage (NET) study of chest pain patients: a long term evaluation study of a service development aimed at improving the management of patients with non-ST-elevation acute coronary syndromes |
| Q49088428 | One-year and longer dual antiplatelet therapy after an acute coronary syndrome: a Belgian position paper |
| Q43142042 | Opportunities for improving global cardiovascular quality of care and outcomes |
| Q33554381 | Oral antiplatelet therapy for acute and chronic management of NSTE ACS: residual ischemic risk and opportunities for improvement |
| Q37436743 | Orphan targets for reperfusion injury. |
| Q35100813 | Pain-to-hospital times, cardiovascular risk factors, and early intrahospital mortality in patients with acute myocardial infarction. |
| Q38786427 | Pedal Edema as an Indicator of Early Heart Failure in the Community: Prevalence and Associations With Cardiac Structure/Function and Natriuretic Peptides (MESA [Multiethnic Study of Atherosclerosis]). |
| Q42722557 | Performance measurement and equity |
| Q40605415 | Personality factors and depression as predictors of hospital-based health care utilization following acute myocardial infarction |
| Q37765228 | Polypill: lights and shadows. |
| Q37809122 | Poor responsiveness to antiplatelet drugs in acute coronary syndromes: clinical relevance and management. |
| Q37900083 | Post myocardial infarction cardiogenic shock: a review of current therapies |
| Q33910673 | Post-acute care services received by older adults following a cardiac event: a population-based analysis |
| Q37707154 | Practice of ST-segment elevation myocardial infarction care in the Netherlands during four snapshot weeks with the National Cardiovascular Database Registry for Acute Coronary Syndrome |
| Q37796438 | Prasugrel as Antiplatelet Therapy in Patients With Acute Coronary Syndromes or Undergoing Percutaneous Coronary Intervention |
| Q31116489 | Pre- and in-hospital antithrombotic management patterns and in-hospital outcomes in patients with acute coronary syndrome: data from the Turkish arm of the EPICOR study |
| Q58292876 | Pre-hospital treatment of STEMI patients. A scientific statement of the Working Group Acute Cardiac Care of the European Society of Cardiology |
| Q36645766 | Predictive models for short- and long-term adverse outcomes following discharge in a contemporary population with acute coronary syndromes |
| Q104137161 | Predominant subtype of heart failure after acute myocardial infarction is heart failure with non-reduced ejection fraction |
| Q56991534 | Prescription at discharge of recommended treatments for secondary prevention in patients with ST-segment elevation myocardial infarction according to reperfusion strategies. Results from the IN-ACS outcome study |
| Q26797762 | Prevalence, treatments and outcomes of coronary artery disease in Indians: A systematic review |
| Q42331995 | Preventive percutaneous coronary intervention and aspiration thrombectomy-updates in the management of ST-elevation myocardial infarction |
| Q92218839 | Professor Keith AA Fox |
| Q38886852 | Prognosis of Low Normal Left Ventricular Ejection Fraction in an Asymptomatic Population-Based Adult Cohort: The Multiethnic Study of Atherosclerosis. |
| Q36309695 | Prognostic Impact of In-Hospital and Postdischarge Heart Failure in Patients With Acute Myocardial Infarction: A Nationwide Analysis Using Data From the Cardiovascular Disease in Norway (CVDNOR) Project |
| Q43262555 | Prognostic value of admission blood glucose concentration and diabetes diagnosis on survival after acute myocardial infarction: results from 4702 index cases in routine practice |
| Q37240704 | Prolonged High-Dose Bivalirudin Infusion Reduces Major Bleeding Without Increasing Stent Thrombosis in Patients Undergoing Primary Percutaneous Coronary Intervention: Novel Insights From an Updated Meta-Analysis |
| Q26778567 | Quality markers in cardiology: measures of outcomes and clinical practice--a perspective of the Spanish Society of Cardiology and of Thoracic and Cardiovascular Surgery |
| Q24623137 | RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome |
| Q37288480 | Recent Advances in the Treatment of ST-Segment Elevation Myocardial Infarction |
| Q37882714 | Recent developments in the use of antiplatelet agents to prevent cardiovascular events |
| Q34025138 | Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI. |
| Q35949260 | Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995-2006. |
| Q37283470 | Regenerative cell therapy and pharmacotherapeutic intervention in heart failure: Part 1: Cardiovascular progenitor cells, their functions and sources |
| Q43251940 | Regenerative cell therapy and pharmacotherapeutic intervention in heart failure: Part 2: Pharmacological targets, agents and intervention perspectives |
| Q22241917 | Reperfusion Strategies in Acute Coronary Syndromes |
| Q35750305 | Reperfusion for STEMI in current Canadian practice: Are we closing the care gap? |
| Q51400303 | Resolving inequalities in care? Reduced mortality in the elderly after acute coronary syndromes. The Myocardial Ischaemia National Audit Project 2003-2010. |
| Q58671322 | Response to AMA's Council on Ethical and Judicial Affairs draft report on "Ethical guidance for physicians and the profession with respect to industry support for professional education in medicine" |
| Q26824114 | Restrictions on interactions between doctors and industry could ultimately hurt patients |
| Q47128198 | Return to Work and Risk of Subsequent Detachment From Employment After Myocardial Infarction: Insights From Danish Nationwide Registries |
| Q43085556 | Return to work after an acute coronary syndrome: patients' perspective |
| Q37462115 | Risk factors for heart failure: a population-based case-control study |
| Q45962605 | Rivaroxaban in acute coronary syndromes: too soon to know? |
| Q37788728 | Role of Antiischemic Agents in the Management of Non‐ST Elevation Acute Coronary Syndrome (NSTE‐ACS) |
| Q33812907 | Role of cardiovascular magnetic resonance in assessment of acute coronary syndrome |
| Q26471900 | Routine invasive strategies versus selective invasive strategies for unstable angina and non-ST elevation myocardial infarction in the stent era |
| Q37951403 | Routine invasive versus conservative management in non-ST-elevation acute coronary syndromes. |
| Q41834772 | Routine pretreatment with abciximab versus standard periprocedural therapy in mechanically ventilated cardiogenic shock patients undergoing primary percutaneous coronary intervention: Subanalysis of the PRAGUE-7 study |
| Q33776384 | Secular trends in acute coronary syndrome hospitalization from 1994 to 2005. |
| Q46760225 | Short- and long-term prognostic value of the TIMI risk score after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction |
| Q40571070 | Socio-economic position and time trends in invasive management and case fatality after acute myocardial infarction in Denmark |
| Q37078799 | Specialized centers and systems for heart attack care |
| Q45720927 | Standing alone when life takes an unexpected turn: being a midlife next of kin of a relative who has suffered a myocardial infarction |
| Q36141760 | Systemic Atherosclerotic Inflammation Following Acute Myocardial Infarction: Myocardial Infarction Begets Myocardial Infarction |
| Q37445883 | Target populations and relevant therapeutic end points to further improve outcomes in NSTEACS patients |
| Q37077311 | Technology Insight: magnetic navigation in coronary interventions |
| Q37278711 | Telomere biology in heart failure |
| Q37387217 | Temporal Trends in Clinical Outcomes Following Percutaneous Coronary Intervention in Patients with Renal Insufficiency |
| Q48168034 | Temporal changes in treatments and outcomes after acute myocardial infarction among cancer survivors and patients without cancer, 1995 to 2013. |
| Q38782804 | Temporal trends in acute myocardial infarction presentation and association with use of cardioprotective drugs: A nationwide registry-based study |
| Q38397398 | Temporal trends in the treatment and outcomes of elderly patients with acute coronary syndrome |
| Q34139585 | Temporal trends in the use of intraaortic balloon pump associated with percutaneous coronary intervention in the United States, 1998-2008 |
| Q36856802 | The "number needed to treat" turns 20--and continues to be used and misused |
| Q89538621 | The AngelMed Guardian® System in the Detection of Coronary Artery Occlusion: Current Perspectives |
| Q58696046 | The Effects of Geography on Outcomes of Routine Early Versus Selective Late Revascularization Strategy in the Treatment of Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction: A Meta-Analysis of Transatlantic Randomized Controlled Tria |
| Q37295202 | The Saudi Project for Assessment of Coronary Events (SPACE) registry: design and results of a phase I pilot study |
| Q34644992 | The continuum of personalized cardiovascular medicine: a position paper of the European Society of Cardiology |
| Q37356505 | The effect of a short one-on-one nursing intervention on knowledge, attitudes and beliefs related to response to acute coronary syndrome in people with coronary heart disease: a randomized controlled trial |
| Q53120173 | The effect of referral for cardiac rehabilitation on survival following acute myocardial infarction: a comparison survival in two cohorts collected in 1995 and 2003. |
| Q47258737 | The platelet phenotype in patients with ST-segment elevation myocardial infarction is different from non-ST-segment elevation myocardial infarction |
| Q48280475 | The race for higher sensitivity troponins, but for what prize? |
| Q28273799 | Therapeutic impact of follistatin-like 1 on myocardial ischemic injury in preclinical models |
| Q35146193 | Thirty-year (1975 to 2005) trends in the incidence rates, clinical features, treatment practices, and short-term outcomes of patients <55 years of age hospitalized with an initial acute myocardial infarction |
| Q37315638 | Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective |
| Q57243459 | Time course of events in acute coronary syndromes: implications for clinical practice from the GRACE registry |
| Q51273826 | Timing and long-term prognosis of recurrent MI after primary angioplasty : Stent thrombosis vs. non-stent-related reinfarction. |
| Q35820226 | Total saponins from Aralia taibaiensis protect against myocardial ischemia/reperfusion injury through AMPK pathway. |
| Q33599555 | Transradial versus transfemoral approach in patients undergoing percutaneous coronary intervention for acute coronary syndrome. A meta-analysis and trial sequential analysis of randomized controlled trials |
| Q93706508 | Treatment trends are going the right way in acute coronary syndrome |
| Q37328685 | Trends from 1996 to 2007 in incidence and mortality outcomes of heart failure after acute myocardial infarction: a population-based study of 20,812 patients with first acute myocardial infarction in Western Australia |
| Q36835957 | Trends in Mortality Following Acute Myocardial Infarction Among Dialysis Patients in the United States Over 15 Years |
| Q50732528 | Trends in hospital treatments, including revascularisation, following acute myocardial infarction, 2003-2010: a multilevel and relative survival analysis for the National Institute for Cardiovascular Outcomes Research (NICOR). |
| Q34425300 | Trends in postacute myocardial infarction management and mortality in patients with diabetes. A population-based study from 1995 to 2001 |
| Q38823420 | Trends in the risk of early and late-onset heart failure as an adverse outcome of acute myocardial infarction: A Cardiovascular Disease in Norway project |
| Q37517246 | Trends in time to invasive examination and treatment from 2001 to 2009 in patients admitted first time with non-ST elevation myocardial infarction or unstable angina in Denmark |
| Q36122233 | Trends of 28 days case fatality rate after first acute myocardial infarction in Isfahan, Iran, from 2000 to 2009. |
| Q38632527 | Triage of Septic Patients Using qSOFA Criteria at the SAMU Regulation: A Retrospective Analysis |
| Q37280893 | Twenty-year trends in the incidence of stroke complicating acute myocardial infarction: Worcester Heart Attack Study |
| Q35821325 | Ubiquitin-free routes into the proteasome |
| Q46637686 | Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK-Belgian Study). |
| Q41265471 | Update on pharmacological treatment of acute coronary syndrome without persistent ST segment elevation myocardial infarction in the elderly |
| Q61866159 | Update on phase II studies of erythropoietin in acute myocardial infarction. Rationale and design of Exogenous erythroPoietin in Acute Myocardial Infarction: New Outlook aNd Dose Association Study (EPAMINONDAS) |
| Q34211280 | Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey |
| Q51157328 | [Epidemiology of acute coronary syndromes in France and in Europe]. |
| Q83898530 | [From study to standard to systems of care: ongoing needs to increase evidence adoption] |
| Q87458506 | [Procedural aspects in primary PCI: arterial access, stent selection, thrombectomy and treatment of non-culprit lesions] |
| Q33758547 | β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction. |
| Q26829973 | 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Associat |
| Q26828766 | 2013 ACCF/ACR/ASE/ASNC/SCCT/SCMR appropriate utilization of cardiovascular imaging in heart failure: a joint report of the American College of Radiology Appropriateness Criteria Committee and the American College of Cardiology Foundation Appropriate |
| Q22242895 | ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment el |
Search more.